Gene · 4547
Papers2,741
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,741
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of LXR inverse agonists to treat MAFLD, NASH, and other metabolic diseases. | Front Med (Lausanne) | 2023 | 36817797 | PubTator, text mining | PubMed |
| The effect of PCSK9 immunization on the hepatic level of microRNAs associated with the PCSK9/LDLR pathway. | Arch Med Sci | 2023 | 36817686 | PubTator, text mining | PubMed |
| The role of FOXA family transcription factors in glucolipid metabolism and NAFLD. | Front Endocrinol (Lausanne) | 2023 | 36798663 | PubTator, text mining | PubMed |
| Repositioning Lomitapide to block ZDHHC5-dependant palmitoylation on SSTR5 leads to anti-proliferation effect in preclinical pancreatic cancer models. | Cell Death Discov | 2023 | 36774350 | PubTator, text mining | PubMed |
| Validation of Knock-Out Caco-2 TC7 Cells as Models of Enterocytes of Patients with Familial Genetic Hypobetalipoproteinemias. | Nutrients | 2023 | 36771214 | PubTator, text mining | PubMed |
| Inflammation and Obesity: The Pharmacological Role of Flavonoids in the Zebrafish Model. | Int J Mol Sci | 2023 | 36769222 | PubTator, text mining | PubMed |
| Maternal procymidone exposure has lasting effects on murine gut-liver axis and glucolipid metabolism in offspring. | Food Chem Toxicol | 2023 | 36764477 | PubTator, text mining | PubMed |
The effects of pemafibrate and omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, parallel group trial in Japan (PROUD48 study). | Front Cardiovasc Med | 2023 | 36760560 | PubTator, text mining | PubMed |
| From worms to humans: Understanding intestinal lipid metabolism via model organisms. | Biochim Biophys Acta Mol Cell Biol Lipids | 2023 | 36738984 | PubTator, text mining | PubMed |
| Atherosclerotic plaque regression in homozygous familial hypercholesterolaemia: a case report of a long-term lipid-lowering therapy involving LDL-receptor-independent mechanisms. | Eur Heart J Case Rep | 2023 | 36727130 | PubTator, text mining | PubMed |
| Gene editing for dyslipidemias: New tools to "cut" lipids. | Atherosclerosis | 2023 | 36725417 | PubTator, text mining | PubMed |
| Sequential genome-wide CRISPR-Cas9 screens identify genes regulating cell-surface expression of tetraspanins. | Cell Rep | 2023 | 36724073 | PubTator, text mining | PubMed |
| Identification of novel anti-ZIKV drugs from viral-infection temporal gene expression profiles. | Emerg Microbes Infect | 2023 | 36715162 | PubTator, text mining | PubMed |
| Research advances in the understanding of how exosomes regulate ferroptosis in cancer. | Clin Transl Oncol | 2023 | 36705798 | PubTator, text mining | PubMed |
| Guidelines for the Diagnosis and Treatment of Adult Familial Hypercholesterolemia 2022. | J Atheroscler Thromb | 2023 | 36682773 | PubTator, text mining | PubMed |
| Phage Adsorption to Gram-Positive Bacteria. | Viruses | 2023 | 36680236 | PubTator, text mining | PubMed |
| Differential Regulation of Glucosylceramide Synthesis and Efflux by Golgi and Plasma Membrane Bound ABCC10. | Nutrients | 2023 | 36678216 | PubTator, text mining | PubMed |
| Metabolic Role of Autophagy in the Pathogenesis and Development of NAFLD. | Metabolites | 2023 | 36677026 | PubTator, text mining | PubMed |
| Lipidomics-Paving the Road towards Better Insight and Precision Medicine in Rare Metabolic Diseases. | Int J Mol Sci | 2023 | 36675224 | PubTator, text mining | PubMed |
| Diagnostic Yield of Genetic Testing for Ocular and Oculocutaneous Albinism in a Diverse United States Pediatric Population. | Genes (Basel) | 2023 | 36672876 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4547/papers?page=16